Reap the cancer-preventing benefits of this common diabetes drug

There’s no “upside” to type 2 diabetes.

There is, however, a hidden benefit in a drug you’re likely taking if you have type 2 diabetes or if you’re pre-diabetic.

The drug is metformin, and as I mentioned earlier this week, it controls blood sugar effectively without any major side effects for most users. And there’s an added bonus: It’s relatively inexpensive due to the fact that it’s a generic drug.

Thanks to these benefits, metformin is considered the go-to drug for millions of type 2 patients all over the world. And this popular botanical-based drug may also yield yet another, more significant benefit: cancer prevention.

Years ago, doctors began to notice an unexpected trend. It seemed that type 2 patients who took metformin had lower rates of cancer compared to patients who used other diabetes drugs.

Researchers quickly leapt into action and they haven’t let up, as the results have been surprisingly promising.

For instance, last year I told you about a trial where researchers tested tumor samples from 39 non-diabetics who had head and neck cancer. After two weeks of using metformin at doses similar to dosage for diabetics (2,000 mg per day), researchers found marked signs of apoptosis (natural cell death) in cancer cells, and a deterioration of fibroblasts (specialized cells that support tumor growth).

In another study published last year, results showed that metformin suppresses pancreatic, breast, colon, and prostate cancer stem cells.

Most recently, a team of Italian scientists investigated the link between thyroid cancer and metabolic disorders such as type 2 diabetes. Reviewing different aspects of this link, they noted that insulin resistance appears to increase thyroid cancer risk.

So could metformin shut down that risk by stabilizing insulin? They believe it could…

Through a recent meta-analysis of 11 studies, they found that overall cancer risk dropped by 30 percent in patients taking metformin compared to those who took other diabetes drugs. And a study in Taiwan showed specifically that metformin use reduced the risk of thyroid cancer. Other research shows that metformin appears to reduce the volume of solid thyroid nodules, which can develop into cancer.

In Dr. Marc Micozzi’s Authentic Anti-Cancer Protocol, he cites research in which type 2 patients who did develop cancer had better survival rates compared to patients who took other types of diabetes medications.

But metformin isn’t perfect. It can trigger side effects, which tend to be mostly mild gastrointestinal problems. And the drug does prompt an odd deficiency Dr. Micozzi warns about. He says, “Metformin can cause vitamin B depletion. So if you take metformin, make sure to take a good, quality B-supplement as well.”

Dr. Micozzi recommends a quality vitamin B complex supplement that contains the following:

  • Vitamin B1 (thiamine) — 50 mg
  • Vitamin B2 (riboflavin) — 50 mg
  • Vitamin B3 (niacin or niacinamide) — 50 mg
  • Vitamin B4 (choline) — 50 mg
  • Vitamin B5 (pantothenic acid) — 50 mg
  • Vitamin B6 — 50 mg
  • Vitamin B7 (biotin) — 100 mcg
  • Vitamin B9 (folic acid) — 400 mcg, minimum
  • Vitamin B12 (cobalamin) — 12 mcg

Dr. Micozzi notes that a vitamin B-12 supplement is especially important as it protects the nerves and helps to prevent peripheral neuropathy — a major health issue for diabetics.

The last thing you want to do is take on the pain and neurological danger of neuropathy in exchange for lower cancer risk.

For more natural pathways to cancer prevention and treatment alternatives, refer to Dr. Micozzi’s Authentic Anti-Cancer Protocol You can learn more about this protocol, as well as his entire catalog of learning courses, simply by clicking here.

 

SOURCES

https://www.frontiersin.org/articles/10.3389/fendo.2017.00314/full
Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?
Frontiers in Endocrinology
November 14, 2017

Will Diabetes Drug Metformin Protect the Thyroid?


Will Diabetes Drug Metformin Protect the Thyroid?
People’s Pharmacy
January 29, 2018